Invokana (Canagliflozin) & Renal Cell Carcinoma

    Basic Details
    Status
    Ongoing
    Last Updated
    Monday, March 4, 2019
    Original Posting Date
    Health Outcome(s)
    renal cell carcinoma
    Purpose
    Drug and Outcome Analysis
    Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR
    Yes